PROGRAM CHAIR

PROGRAM OVERVIEW

The goal of this program is to increase the healthcare professional’s (HCP) ability to: analyze clinical data with use of HER2-targeted antibody-drug conjugates in HER2-expressing solid tumors; identify potential adverse events associated with HER2-targeted antibody-drug conjugates; and evaluate the need to accurately assess HER2 status in HER2-expressing solid tumors to facilitate use of HER2-targeted antibody-drug conjugates when appropriate.

TARGET AUDIENCE

This activity is intended for US-based community oncology teams, including oncologists and multidisciplinary HCPs involved in the treatment of patients with HER2-positive solid tumors, including gynecological, bladder, and biliary tract cancers.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Analyze clinical data with use of HER2-targeted antibody-drug conjugates in HER2-expressing solid tumors
• Identify potential adverse events associated with HER2-targeted antibody-drug conjugates
• Evaluate the need to accurately assess HER2 status in HER2-expressing solid tumors to facilitate use of HER2-targeted antibody-drug conjugates when appropriate

JOINT ACCREDITATION STATEMENT

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this virtually live activity for a maximum of 1.5 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CE credit for this activity.  

In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.

Your certificate will be provided as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science-based.

This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

 

 

Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only.  Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.